相似文献
1
IL28B genotype and the expression of ISGs in normal liver.
Liver Int. 2013 Aug;33(7):991-8. doi: 10.1111/liv.12148. Epub 2013 Mar 24.
2
Hepatic cell-type specific gene expression better predicts HCV treatment outcome than IL28B genotype.
Gastroenterology. 2012 May;142(5):1122-1131.e1. doi: 10.1053/j.gastro.2012.01.028. Epub 2012 Jan 25.
3
Association between IL28B gene polymorphisms and plasma HCV-RNA levels in HIV/HCV-co-infected patients.
AIDS. 2011 Mar 27;25(6):761-6. doi: 10.1097/QAD.0b013e32834488e7.
4
IL28B gene polymorphisms and US liver fatty changes in patients who spontaneously cleared hepatitis C virus infection.
PLoS One. 2013 Aug 1;8(8):e67301. doi: 10.1371/journal.pone.0067301. Print 2013.
5
IL28B gene polymorphism rs12979860, but not rs8099917, contributes to the occurrence of chronic HCV infection in Uruguayan patients.
Virol J. 2018 Mar 2;15(1):40. doi: 10.1186/s12985-018-0946-2.
6
Increased risk of severe hepatitis C virus recurrence after liver transplantation in patients with a T allele of IL28B rs12979860.
Transplantation. 2012 Aug 15;94(3):275-80. doi: 10.1097/TP.0b013e31825668f6.
7
Strong prediction of virological response to combination therapy by IL28B gene variants rs12979860 and rs8099917 in chronic hepatitis C genotype 4.
Liver Int. 2014 Jul;34(6):890-5. doi: 10.1111/liv.12321. Epub 2013 Oct 14.
8
Association of gene expression involving innate immunity and genetic variation in interleukin 28B with antiviral response.
Hepatology. 2012 Jan;55(1):20-9. doi: 10.1002/hep.24623. Epub 2011 Nov 29.
9
Inverse association of IL28B genotype and liver mRNA expression of genes promoting or suppressing antiviral state.
J Med Virol. 2011 Sep;83(9):1597-607. doi: 10.1002/jmv.22158.
10
Impact of IL28B gene polymorphisms on interferon-λ3 plasma levels during pegylated interferon-α/ribavirin therapy for chronic hepatitis C in patients coinfected with HIV.
J Antimicrob Chemother. 2012 May;67(5):1246-9. doi: 10.1093/jac/dkr598. Epub 2012 Feb 1.
引用本文的文献
1
Distribution of Single Nucleotide Polymorphism rs11322783 Genotypes in Patients with COVID-19.
Microorganisms. 2022 Feb 4;10(2):363. doi: 10.3390/microorganisms10020363.
2
Interferon Lambda 3/4 (IFNλ3/4) rs12979860 Polymorphisms Is Not Associated With Susceptibility to Systemic Lupus Erythematosus, Although It Regulates OASL Expression in Patients With SLE.
Front Genet. 2021 Jun 2;12:647487. doi: 10.3389/fgene.2021.647487. eCollection 2021.
3
The Prevalence of Hepatitis C Virus Core Amino Acid 70 Substitution and Genotypes of Polymorphisms Near the IFNL3 Gene in Iranian Patients With Chronic Hepatitis C.
Hepat Mon. 2016 May 3;16(6):e37011. doi: 10.5812/hepatmon.37011. eCollection 2016 Jun.
4
Comparison of Three Different Methods for Detection of IL28 rs12979860 Polymorphisms as a Predictor of Treatment Outcome in Patients with Hepatitis C Virus.
Osong Public Health Res Perspect. 2016 Apr;7(2):83-9. doi: 10.1016/j.phrp.2015.11.004. Epub 2015 Nov 30.
5
Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat.
J Virol. 2015 Oct;89(20):10176-89. doi: 10.1128/JVI.01484-15. Epub 2015 Jul 29.
6
Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease.
Nat Commun. 2015 Mar 5;6:6422. doi: 10.1038/ncomms7422.
7
The Impact of IFNL4 rs12979860 Polymorphism on Spontaneous Clearance of Hepatitis C; A Case-Control Study.
Hepat Mon. 2014 Oct 1;14(10):e22649. doi: 10.5812/hepatmon.22649. eCollection 2014 Oct.
8
Interferon-λ Genetic Variations and Hepatitis C: Yet to be Discovered.
Hepat Mon. 2014 May 10;14(5):e19433. doi: 10.5812/hepatmon.19433. eCollection 2014 May.
9
Individualization of chronic hepatitis C treatment according to the host characteristics.
World J Gastroenterol. 2014 Mar 21;20(11):2839-53. doi: 10.3748/wjg.v20.i11.2839.
10
Genetic variants at the IFNL3 locus and their association with hepatitis C virus infections reveal novel insights into host-virus interactions.
J Interferon Cytokine Res. 2014 Jul;34(7):479-97. doi: 10.1089/jir.2013.0113. Epub 2014 Feb 20.
本文引用的文献
1
IL28B and PNPLA3 polymorphisms affect histological liver damage in patients with non-alcoholic fatty liver disease.
J Hepatol. 2012 Jun;56(6):1356-62. doi: 10.1016/j.jhep.2012.01.007. Epub 2012 Feb 5.
2
Interferon-lambda and therapy for chronic hepatitis C virus infection.
Trends Immunol. 2011 Sep;32(9):443-50. doi: 10.1016/j.it.2011.07.002. Epub 2011 Aug 5.
3
Hepatitis C virus protects human B lymphocytes from Fas-mediated apoptosis via E2-CD81 engagement.
PLoS One. 2011 Apr 19;6(4):e18933. doi: 10.1371/journal.pone.0018933.
4
A diverse range of gene products are effectors of the type I interferon antiviral response.
Nature. 2011 Apr 28;472(7344):481-5. doi: 10.1038/nature09907. Epub 2011 Apr 10.
5
Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance.
Hepatology. 2011 May;53(5):1446-54. doi: 10.1002/hep.24263.
6
IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway.
J Hepatol. 2011 Aug;55(2):289-98. doi: 10.1016/j.jhep.2010.11.019. Epub 2010 Dec 13.
7
Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients.
J Hepatol. 2011 Mar;54(3):415-21. doi: 10.1016/j.jhep.2010.07.041. Epub 2010 Sep 22.
8
Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C.
Gastroenterology. 2011 Mar;140(3):1021-31. doi: 10.1053/j.gastro.2010.11.039. Epub 2010 Nov 25.
9
IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C.
Hepatology. 2010 Dec;52(6):1888-96. doi: 10.1002/hep.23912. Epub 2010 Oct 7.
10
Peripheral blood memory B cells are resistant to apoptosis in chronic hepatitis C patients.
Virus Res. 2011 Jan;155(1):349-51. doi: 10.1016/j.virusres.2010.09.017. Epub 2010 Sep 25.
Zotero 插件